that the short trade has gotten a bit crowded. EXEL has relatively strong to it's biotech peers institutional ownership at 67%, roughly a 100 million shares. Does this have any effect on the risk of going short? I posted a couple days ago the short trade appears relatively safe near term simply due to slow news flow. But..has this become a short trap? I wonder..with an ever increasingly crowded trade, the exit gets smaller and smaller. There is huge money with stakes in EXEL (Fidelity alone has 15%)...is it even necessary to speculate on what is possible... might be wishful thinking...just sayin.
ssshhhh, if you say it real quietly, squeeeeze,,,, maybe they won't know what hit them. What we need is some good rumor or maybe some good fact that triggers a buy from any of the analysts following the stock.
I hope it happens before Adam Feurstein and his short-fund friends don't decide to do anther hatchet job.